Together, these findings are consistent with the switch of epithelial TGFβ signalling from a tumour suppressor to a tumour promoter, in the context of concurrent Apc and Kras mutations, and underscore the fact that the output of TGFβ signalling is highly contextual. This evidence concerns the gene KRAS and neoplasm.